The polyspecific antibody synthesis in multiple sclerosis (MS) gained diagnostic relevance with the frequent combination of measles-, rubella-and varicella zoster antibodies (MRZ-antibody reaction) but their pathophysiological role remains unknown. This review connects the data for intrathecal polyspecific antibody synthesis in MS and neurolupus with observations in the blood of patients with Guillain-Barré syndrome (GBS). Simultaneously increased antibody and autoantibody titers in GBS blood samples indicate that the polyspecific antibodies are based on a general property of an immune network, supported by the deterministic day-to-day concentration variation of antibodies in normal blood. Strongly correlated measles-and rubella-antibody variations point to a particular connectivity between the MRZ antibodies. The immune network, which provides serological memory in the absence of an antigen, implements the continuous change of the MRZ pattern in blood, not followed by the earlier immigrated B cells without corresponding connectivity in the brain. This may explain the different antibody patterns in cerebrospinal fluid, aqueous humor and blood of the individual MS patient. A complexity approach must implement a different view on causation in chronic diseases and causal therapies.
The polyspecific antibody synthesis in the brain of multiple sclerosis (MS) patients 1 was, and still is, a permanent motivation to search for a causative antigen. But, as shown in a meta analysis 2 , in 60 years of research with 5,800 epitopes investigated, no causative function could unambiguously be identified for autoimmune diseases or multiple sclerosis. There is still poor acceptance of an antibody synthesis in the absence of a B cell activating antigen in the brain 1 . Another irritation in the research of chronic diseases comes from a clear statistical correlation between infections and autoimmune diseases, including MS 3 . This connection is supported by the association of vaccinations with a three-week to two-month delayed appearance of multi-symptom diseases, like Gulf war illness, chronic fatigue or Guillain-Barré syndrome 4, 5, 6 . This shows that there is a basic deficit in the understanding of the causation of chronic diseases; in fact, of the nature of chronic disease at all 4 
.
It is the intention of this review to provide a closer look at the characteristics of the polyspecific antibody response and its role in the pathological process. For this purpose, this article reviews the knowledge about polyspecific antibodies in autoimmune diseases with involvement of the CNS 7 , as well as the polyspecific antibody pattern with an individual connectivity in the blood of patients with a Guillain-Barré syndrome (GBS) 8 , as an extension to the better-characterized reactions in MS 1, 9, 10, 11 . In particular, the correlations between the day-to-day variations of individual antibody concentrations shown in the blood of controls may help to get a better acceptance for the connectivity between antibodies as a general property of an immune network 12 .
MULTIPLE SCLEROSIS
The basic knowledge about the polyspecific antibodies comes from the sensitive detection and interpretation of the specific Antibody Index as a relative value 11 and the quantitative specific fraction, Fs, the amount of the intrathecally-synthesized antibody species as a fraction of the amount of the total intrathecally-synthesized IgG 13, 14 . The individual antibody species can also be shown as part of the oligoclonal bands in cerebrospinal fluid (CSF) 15 . The measles-, rubella-, varicella zoster-antibodies have a much higher frequency compared to the other antibody species analyzed
11
. The combined analysis, the so-called MRZ antibody reaction 9 , is the most sensitive measure for the detection of a polyspecific antibody synthesis, and this gained diagnostic relevance for detection of a chronic inflammatory process in the brain 10, 16, 17, 18, 19 . The MRZ antibody reaction is typical in chronic diseases, but missing in acute inflammatory diseases. Table  1 shows that a typical MRZ reaction with a combination of ≥ 2 antibodies (AB) was found in 28/29 MS patients but not in any (0/125) of the bacterial or viral neurological diseases investigated. Only a sporadic single antibody species of M, R or Z was detectable in a small fraction (10/125) of the acute inflammatory diseases (1 AB in Table1). Diagnosis of neurotuberculosis and neuroborreliosis fulfilled the criteria published 10, 11 . Data of bacterial meningitis, general viral infections and HSV/VZV encephalitis were analysed and compiled by M. Albrecht in the Neurochemistry laboratory, University Goettingen.
But, in spite of the absence of a polyspecific MRZ reaction, the amount of the disease-specific antibodies in the acute inflammatory diseases remain still a minor fraction with a mean of 10-20% of total intrathecal IgG in acute or antigen-driven immune reactions 13, 14, 20 . A theoretically important observation was the correlation of an increased frequency and an increased amount of MRZ antibodies at a larger intrathecal total IgG concentration 9 .
As shown in Figure 1 , the mean number of combined antibody species (n = 0-3) is higher in a larger amount of intrathecal total IgG (IgG loc in mg/l), i.e., the probability of finding all three MRZ antibodies synthesized in CNS increases with the amount of intrathecal total IgG, asymptotically approaching the maximal value n = 3 9 . . The mean amount of intrathecal total IgG in each interval with 20 patients was calculated with reference to a Qmean as IgGloc(mean) in mg/l CSF 8 with the CSF statistics program of www.albaum.it. The mean number of combined antibodies in each interval was calculated with (n 1 +2n 2 + 3n 3 ) / n. (n = number of patients with one (n 1 ), two (n 2 ) or three (n 3 ) antibodies in CSF).
The total amount of intrathecal IgG cannot be interpreted as it depends on the nearness of the perivascular lymphocyte cuffs to the CSF space, which must be in reach for the diffusion process 11 . This view of a mere statistical combination, then a specificity-dependent migration of B cells into the brain, was supported by the different local antibody patterns in the brain and in the eye of the individual MS patient 1 , which shows that the immigrating B cell clones in the brain have local, arbitrarily different, antibody specificities 1 . From further investigations, the following was also learned: In a virus-driven immune response, the mean specific antibody concentration is 20-60-fold stronger compared with polyspecific antibodies of the same specificity 13, 14, 20 . The polyspecifc antibodies in MS are based on the precondition of a wild type infection or vaccination, but not on any mimicking antigens 1, 21 . The intrathecal synthesis of autoantibodies against dsDNA 7 with a frequency of 19% is comparable to the average of other antibodies
. The high affinity of polyspecific antibodies in the CSF 22, 23 , in contradiction to an earlier biased report 24 , is an important argument that the immigrating B cells are affinity-maturated in the lymph system and not in the brain
The polyspecific antibodies have, in general, a long-lasting stable concentration in the CSF 25 , different from the exponential decay of antibody concentrations in acute inflammatory diseases 26 .
Neither the amount of the MRZ antibodies in blood, nor their ranked sequence (blood pattern), correlates with the MRZ pattern in the CSF
13
. This observation is consistent with the locally different patterns in the brain and eye 
AUTOIMMUNE DISEASES WITH INVOLVEMENT OF THE CNS
An important extension of knowledge is that the polyspecific antibody response is detectable in autoimmune diseases with involvement of the brain 7 , like neurolupus, Sjögren syndrome and Wegener's granulomatosis or neurosarcoidosis.
The IgG patterns, with the associated blood-CSF barrier functions of neurolupus patients, are shown in an IgG Reibergram in Figure 2 and their corresponding MRZ-antibody combinations are presented in Table 2 7 ; 6/10 patients had an intrathecal antibody synthesis for one to four of the five antibody species investigated: Patient 3 has, together with the large intrathecal total IgG concentration, 4/5 analysed antibodies with an AI > 1.5. 50% above the mean of the lower AI values in CSF of patient 4, the HSV-AI = 1.4 is also calculated as a synthesis, as the value is 50% above the lowest other AI = 0.8. But in case of a HSV + VZV combination the careful exclusion of a herpes encephalitis is important, to avoid a wrong interpretation. The intrathecal ds-DNA autoantibody synthesis (2/10, patients 3 and 9) had to be counted, albeit cases with a neurolupus, as part of a polyspecific immune response, seen at a similar frequency in the MS patients (19%) 11 . This antibody evaluation, with the corrected Antibody Index
11
, was still more sensitive (6/10) than by the detection of oligoclonal IgG 11 (3/10 type 2) or with the quotient diagram (3/10) (Figure 2) 
27
. Four of 10 patients had a slightly increased QAlb, i.e., a decreased CSF flow rate 28 . This is a typical pattern found in chronic diseases with a limited frequency and low amount of pathologically increased QAlb. As explained 11, 28, 29 , this reduced CSF turnover can be the consequence of a reduced elimination, but also of a reduced CSF production rate in the choroid plexus (Table 2) .
Polyspecific antibodies in blood -Guillain-Barré syndrome (GBS)
The polyradiculitis Guillain-Barré or Guillain-Barré syndrome (GBS) is a heterogeneous autoimmune disease of the peripheral nerves. It appears after infections and vaccinations 6 . Lumbar CSF of patients with GBS shows a seriously increased albumin quotient, QAlb, due to the restricted outflow of CSF (Table 2 ). Four (40%) patients had an age-related increased albumin quotient, QAlb, i.e. a decreased CSF flow rate 28 .
Among a large available set of antibody assays in Jim Peter's Specialty Laboratory, Santa Monica, California, the authors found a varying combination of antibodies with increased titers in blood of 56 GBS patients. Table 3 summarizes the interpretation of their results for IgG class (n = 19) and IgM class (n = 3) antibody titers (total n = 22) of the 19 different selected infectious microbes 8 . In the individual blood sample between 0 and 15 different antibody species (out of 22 species analyzed) had simultaneously-increased titers. The distribution of the 56 patients over the number of simultaneouslyincreased titers is shown in Figure 4 . The data are fitted with a Gaussian error function. In spite of this rough evaluation, due to the small number of patients in each group (Table 3) , we can see that in this combination of 22 arbitrary antibody species, the median number of simultaneously-synthesizing B cell clones was about five (at the maximal point of the Gaussian distribution curve). If we suggested a connectivity 30 between the synthesizing B cells, we could interpret this figure as showing a median connectivity of about five antibodysynthesizing B cell clones in the individual patient (maximal connectivity of 15/22 antibody specificities). For the group of autoantibodies (n = 18) also investigated in this study 8 , 11% of the patient samples had a simultaneous increase of more than five structurally different autoantibodies 8 . From these data we have to conclude that the polyspecific antibody response is a basic, general property of the immune system, and not restricted to the brain.
A general methodological remark
The better recognition of the polyspecific nature of the immune response in CSF compared to blood is mainly due to the higher biological sensitivity in CSF: a newly-synthesized fraction in the brain is easier to detect in CSF on top of a relatively low total IgG concentration compared to a new fraction in blood with a mean 500-fold higher total IgG concentration. Rare cases with intense oligoclonal IgG bands after a fresh infection in the blood (subsequently also seen in the CSF) are reported as type 3 and 4 in the interpretation of the isoelectric focusing results 11, 26 .
NORMAL ANTIBODY DYNAMICS IN BLOOD
The dynamics of individual antibodies in the blood of patients without an inflammatory process 31 are shown in Figure 5 by the day-to-day concentration variations. The samples are from patients in an intensive care unit with clinically-indicated daily blood sampling to detect possible nosocomial infections. All titers of the antibodies investigated were normal, i.e. below the clinically-defined cut off value. All samples were analyzed together in the same analytical run (microtiter plates) to avoid a bias by analytical day-to-day imprecisions (intra-assay imprecision CV = 3.5%). For the comparison, the measured concentrations were normalized for the first value = 1. In each sample the concentrations of hemoglobin, albumin and total IgG, IgA and IgM in the blood were controlled to make sure that the day-to-day variation was not an artefact of intensive care conditions 31 . Figure 5 shows the day-to-day concentration variation of individual antibodies in the blood of two different patients. In both cases the correlation between measles and rubella antibody Table 2 . Polyspecific immune response (MRZ reaction) in the brains of patients with neurolupus 7 . The same patients as in Figure 2 . Table 3 . Frequencies of simultaneously-increased antibody titers in the blood of patients with a Guillain-Barré polyradiculitis. These data summarize the results from Table 4 in Terryberry et al. 8 , For comparison: in a nosocomial infection with reactivation of the herpes simplex virus, the HSV antibody concentration steadily increased seven-fold in five days, without remarkable variations in one case, and in another case, the increase was 40-fold combined with an 11-fold increase of varicella-zoster virus antibody concentrations 31 . In both cases, the correspondingly increased titers in blood were recognizable.
These time series with a sequence of daily concentration values measured in humans are more relevant for an interpretation than the early data from mice with a seven day interval 32 . The set of data (< 70-80 uninterrupted serial time points) was too small for a reliable determination of the fractal dimension of the time series 33, 34 . But the combined analysis of several time series according to the power law in double logarithmic diagrams allowed the exclusion of a statistical variation like a Gaussian error function 4, 35, 36 . This allows the conclusion that the time series of antibody concentrations in blood are a deterministic chaotic variation, different from noise. This confirms the earlier suggestions 32 that the cause of the variation is a regulatory process i.e., due to an algorithm of an immune network.
The intrathecal polyspecific antibody synthesis, like the polyspecific antibody activation in GBS, is a consequence of the immune network function with a natural variation of antibody concentrations in blood. Figure 4 . Frequency of Guillain-Barré (GBS) patients (total n = 56, Table 3 ) with the number of simultaneously-increased antibody titers in blood (total n = 22 antibody species analyzed) 8 . The fit with a Gaussian function shows a mean connectivity of five antibody species out of IgG 19 and IgM 3 class antibodies against 19 infectious microbes.
DISCUSSION

Natural dynamics of the immune system
A life-long synthesis of a specific antibody by B lymphocytes in the absence of the antigen has not been easy to explain by the old clonal selection principles 37 . The shorter lifetime of the B cells with a daily renewal of about 20-25% 12 required the understanding of the anti-idiotype network 32, 38 and the polyclonal activation of memory B cells 39 to explain the maintenance of the serological memory.
The basic concepts of the immune network structure had been described about 30 years ago 12, 30, 38, 39, 40 . The GBS data (Table 3 and Figure 4 ) describe the connectivity between antibodies or B cell clones
32
, and the different connectivity 8 from patient to patient describes the individually different network depth of the individual specific antibody or autoantibody (the number of B cell/antibody species involved in the activation cycle
12
). The nonlinear variation of the antibody concentrations provides an example for the nonlinear dynamics in the immune network.
The work of Terryberry et al. 8 , which contributed to this understanding, also represents an example of the enduring struggle with a network thinking 12, 40 , as the authors favoured a causative interpretation 6 based on clonal selection principles.
Locally different MRZ patterns in the brain of MS patients: an explanation
The observation that the MRZ pattern in chronic inflammation in the eye of an individual MS patient with a uveitis intermedia or periphlebitis retinae is different from the MRZ pattern in CSF (10/12 cases) 14 and blood
13
, now has a rational explanation. Due to the continuous development and changes of antibody network depth, the MRZ pattern in blood changes without the intrathecal MRZ pattern, as B cells have no corresponding connectivity in the brain. Therefore, the actual B cell clone population in blood at the time of CSF puncture does not mirror the blood pattern at time of the start of the disease or the inflammation in the eye, which may have happened years after the general start of the disease in the brain 1 
.
In spite of this possible correlation with the MRZ pattern in blood at time of the new bout in MS, the specificity of the immigrating B cells remains inter-individually a statistically arbitrary process as supported by many arguments (e.g. with Figure 1 ), but it does not offer a reason for the persistence of the intrathecal B cell clones and the particularly high frequency of the MRZ species.
Causation in chronic diseases
With the described network view on intrathecal antibody and autoantibody synthesis in MS and autoimmune diseases with involvement of the brain, we cannot pretend that this is not changing our general view on chronic diseases. We obviously have to discriminate between an acute disease with long-lasting complications and an essentially chronic disease. There is a discontinuity between an infection or vaccination and the recognition of an autoimmune disease or multisymptom illnesses of a few weeks to two months 3, 4, 5, 6 after the initiating event. In MS, as well, there is no development such as starting with an acute demyelinating meningoencephalitis and slowly becoming an MS 19, 25 . The youngest patient, investigated at age of five years 25 , already had the complete set of immune reactions, like a complete MRZ antibody reaction 25 . A larger fraction of total MRZ at an older age 25 is just a consequence of the larger total intrathecal IgG 9 as a statistical event (Figure 1 ). The post-puberty frequencies of total MRZ antibodies are also not higher than the prepuberty frequencies 25 . This type of chronic disease has a 'sudden' start. There is the well-known example of sudden hypertension in women on contraceptive hormone treatment. Stopping the hormonal treatment does not reverse the high blood pressure. This is not a dose-effect relationship. The complex system for regulation of blood pressure has switched to a new attractor, the disease is a stable state 4, 41, 42, 43, 44 . The usual medical treatment suppresses only the symptoms but does not change the attractor 36 . There are many more examples described 41, 42 , which started with the recognition of the glucose oscillation 43 as a nonlinear complex system.
The complex system approaches 44, 45 offer a new causation for the development of chronic diseases, which can end the useless search for a causative molecule, agent or antigen 2 . There may be any trigger (infection or vaccination) that facilitates the phase transition between the healthy state and the pathological stable state 4, 44 , as in case of a catalyst that is not a traceable part of the system. The nature of this change (due to amplified local metabolic fluctuations 43 ) also allows the possibility of a spontaneous change to a pathological state of lower complexity 41 without any external influence 4 . The pathological stable state is just the other side of the coin in adaptive biological systems.
Therapy of chronic diseases
The different view on the pathomechanisms of chronic diseases as a stable state of a pathological regulation must also have different therapeutic approaches; in particular, to replace unsatisfying pure treatments of symptoms. Examples of the development of causal therapies in chronic diseases have been reported 4, 45, 46 , but we need further research for suitable applications, different from the linear symptom-oriented solutions of the industrial-medical complex 47, 48 with divergent interests. The blockage of the B cell migration into the brain is a temporary commercial solution, which shows that the B cells are involved in the pathophysiology but, again, this offers no causative therapy.
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